Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1

Interventions

emicizumab 4voxelotor 1romiplostim 1recombinant FVIIa 1olaparib 1maltodextrin 1lusutrombopag 1luspatercept 1ibrutinib 1fludarabine phosphate 1continuous erythropoietin receptor activator 1betrixaban 1anti-inhibitor coagulant complex 1Rituximab 1Pharmacogenomic Testing 1Glutamine 1Factor VIII 1Enoxaparin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × betrixaban × Classical hematology × Clear all
NCT01583218 2023-08-07

APEX

Alexion Pharmaceuticals, Inc.

Phase 3 Completed
7,513 enrolled 18 charts 1 FDA
Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡